We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A preliminary study found that rhBMP-7 ...

Adding to previous evidence, a study based on a statewide cancer database shows no increase in cancer risk in patients undergoing spinal fusion surgery with the bone-promoting growth factor ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Medtronic Inc. has submitted a premarket approval ...

Recombinant bone morphogenetic protein-2 (rhBMP-2, Medtronic Inc), used to promote bone growth in spinal fusion surgery, offers little or no benefit over bone graft and may be associated with more ...

July 2, 2008 — Life-threatening complications have been reported with off-label use of bone morphogenetic protein (rhBMP) in cervical spine fusion, the US Food and Drug Administration (FDA) warned ...

MINNEAPOLIS--(BUSINESS WIRE)-- Following is a statement from Omar Ishrak, chairman and chief executive officer of Medtronic, Inc. (NYSE: MDT) on a series of articles on recombinant human Bone ...

- The bone graft incorporating rhBMP-2 has received FDA IDE approval for a pivotal clinical trial in spinal fusion - Positioned for global expansion in $750M spinal bone graft market NOVOSIS PUTTY, ...

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced a strategic partnership agreement with ...